Genocea Biosciences (NASDAQ:GNCA) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report issued on Monday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The company has a debt-to-equity ratio of 0.24, a current ratio of 1.35 and a quick ratio of 1.35. The company has […]
StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report issued on Monday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The company has a debt-to-equity ratio of 0.24, a current ratio of 1.35 and a quick ratio of 1.35. The company has […]
